SIM
EDSA icon

Spark Investment Management’s Edesa Biotech EDSA Stock Holding History

Spark Investment Management’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-51
Closed -$96K – 784
2015
Q4 		$96K Buy
+51
New +$118K 0.01% 663

Other funds holding EDSA

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return

Spark Investment Management's EDSA Position: Q1 2016 in Review

Spark Investment Management sold out of Edesa Biotech (EDSA) in Q1 2016, closing a stake of 51 shares — an estimated $96K sold.

Spark Investment Management first reported a position in EDSA in Q4 2015 and held it in 1 quarter. The position peaked at $96K in Q4 2015. 15 funds tracked by Wall St. Rank hold EDSA as of Q1 2016.

  • Spark Investment Management reported no remaining Edesa Biotech position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 51 Edesa Biotech shares in Q1 2016, an estimated $96K.
  • Spark Investment Management first reported a position in Edesa Biotech in Q4 2015 and held it in 1 quarter.
  • Spark Investment Management's Edesa Biotech position peaked at $96K in Q4 2015.
  • 15 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.